Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Biotech Stocks Emerge Unscathed And Ready To Go
Article By:
Tarun Chandra, CFA
Friday, May 18, 2018 8:41 PM EDT
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Endocyte Announces Closing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Friday, March 2, 2018 9:35 PM EDT
Endocyte, Inc. announced today the closing of an underwritten registered public offering of 20,535,714 shares of its common stock.
In this article: ECYT
Endocyte Announces Pricing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Wednesday, February 28, 2018 12:07 PM EDT
Endocyte, Inc. today the pricing of an underwritten registered public offering of 17,857,143 shares of its common stock at a price to the public of $4.20 per share.
In this article: ECYT
Best Stock Charts - Wednesday, April 5
Article By:
Robert Desmond
Wednesday, April 5, 2017 11:29 PM EDT
Overall our opinion on the market is that they are weak and getting weaker. We are focusing in on shorting the markets to make big profits to short side.
In this article: ECYT, QQQ, BBBY, CBOE, FIZZ, SCHN, COOL, RCON, GDX, GLD, IWM, NUGT, TZA, UUP, ALDX, AAOI